Award
NIH Reporter #5R01HL160921-04
Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH)
Recipient
LURIE CHILDREN'S HOSPITAL OF CHICAGO, CHICAGO, IL, UNITED STATES
Award Amount
$1,762,069.00
Ceiling
$1,762,069.00
Awarded
June 01, 2026
Identifier
5R01HL160921-04
NIH-funded research project studying the impact of maternal gestational metabolic health on offspring cardiovascular health and disease risk, using clinical and epigenetic methods.
Description
This study aims to investigate the in utero origins of offspring cardiovascular health (CVH) and cardiovascular disease (CVD), leveraging the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study cohort. The research will examine associations between maternal gestational metabolic health and offspring CVH and subclinical CVD in young adulthood, including carotid ultrasonography and DNA methylation analyses.